TheStreet 10-Q 7 Aug 15 2015 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2015	Aug. 04, 2015
Document And Entity Information
Entity Registrant Name	THESTREET, INC.
Entity Central Index Key	1,080,056
Document Type	10-Q
Document Period End Date	Jun. 30, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		34,853,538
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,015

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Current Assets:
Cash and cash equivalents	$ 31,341,423	$ 32,459,009
Accounts receivable, net of allowance for doubtful accounts of $316,728 as of June 30, 2015 and $318,141 as of December 31, 2014	$ 4,316,856	5,103,899
Marketable securities		2,009,240
Other receivables, net	$ 496,432	549,933
Prepaid expenses and other current assets	1,206,180	987,693
Restricted cash	500,000	639,750
Total current assets	37,860,891	41,749,524
Property and equipment, net of accumulated depreciation and amortization of $4,319,226 as of June 30, 2015 and $4,003,538 as of December 31, 2014	3,261,646	2,926,825
Marketable securities	1,540,000	1,560,000
Other assets	359,700	77,052
Goodwill	44,265,776	44,810,467
Other intangibles, net of accumulated amortization of $14,355,277 as of June 30, 2015 and $12,896,782 as of December 31, 2014	19,617,815	20,147,209
Restricted cash	661,250	661,250
Total assets	107,567,078	111,932,327
Current Liabilities:
Accounts payable	2,520,577	2,474,737
Accrued expenses	4,266,659	6,279,082
Deferred revenue	27,409,460	26,427,816
Other current liabilities	934,701	1,241,508
Total current liabilities	35,131,397	36,423,143
Deferred tax liability	1,095,017	728,899
Other liabilities	6,922,736	6,910,175
Total liabilities	43,149,150	44,062,217
Stockholders' Equity
Preferred stock; $0.01 par value; 10,000,000 shares authorized; 5,500 issued and outstanding as of June 30, 2015 and December 31, 2014; the aggregate liquidation preference totals $55,000,000 as of June 30, 2015 and December 31, 2014	55	55
Common stock; $0.01 par value; 100,000,000 shares authorized; 42,096,722 shares issued and 34,852,123 shares outstanding as of June 30, 2015, and 41,967,369 shares issued and 34,727,641 shares outstanding as of December 31, 2014	420,967	419,674
Additional paid-in capital	270,692,680	271,943,049
Accumulated other comprehensive loss	(771,533)	(227,476)
Treasury stock at cost; 7,244,599 shares as of June 30, 2015 and 7,239,728 shares as of December 31, 2014	(12,919,920)	(12,908,943)
Accumulated deficit	(193,004,321)	(191,356,249)
Total stockholders' equity	64,417,928	67,870,110
Total liabilities and stockholders' equity	$ 107,567,078	$ 111,932,327

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Allowance for doubtful accounts (in dollars)	$ 316,728	$ 318,141
Accumulated depreciation and amortization (in dollars)	4,319,226	4,003,538
Accumulated amortization (in dollars)	$ 14,355,277	$ 12,896,782
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	5,500	5,500
Preferred stock, shares outstanding	5,500	5,500
Preferred stock, aggregate liquidation preference (in dollars)	$ 55,000,000	$ 55,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	42,096,722	41,967,369
Common stock, shares outstanding	34,852,123	34,727,641
Treasury stock, shares	7,244,599	7,239,728

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Net revenue:
Subscription services	$ 13,983,871	$ 11,557,413	$ 28,080,933	$ 23,007,280
Media	3,153,048	3,204,841	5,946,035	6,144,052
Total net revenue	17,136,919	14,762,254	34,026,968	29,151,332
Operating expense:
Cost of services	8,585,978	7,676,619	16,909,669	15,414,584
Sales and marketing	4,113,677	3,758,584	8,624,766	7,859,869
General and administrative	3,683,619	3,278,484	7,471,490	6,257,054
Depreciation and amortization	1,137,442	721,511	2,115,678	1,457,372
Total operating expense	17,520,716	15,435,198	35,121,603	30,988,879
Operating loss	(383,797)	(672,944)	(1,094,635)	(1,837,547)
Net interest (expense) income	(32,872)	31,457	(66,405)	69,935
Net loss before income taxes	(416,669)	$ (641,487)	(1,161,040)	$ (1,767,612)
Provision for income taxes	254,591		487,032
Net loss	(671,260)	$ (641,487)	(1,648,072)	$ (1,767,612)
Preferred stock cash dividends	96,424	96,424	192,848	192,848
Net loss attributable to common stockholders	$ (767,684)	$ (737,911)	$ (1,840,920)	$ (1,960,460)
Basic and diluted net loss per share
Net loss attributable to common stockholders	$ (0.02)	$ (0.02)	$ (0.05)	$ (0.06)
Cash dividends declared and paid per common share	$ 0.025	$ 0.025	$ 0.05	$ 0.05
Weighted average basic and diluted shares outstanding	34,848,571	34,367,669	34,814,060	34,287,410

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Statement of Comprehensive Income [Abstract]
Net loss	$ (671,260)	$ (641,487)	$ (1,648,072)	$ (1,767,612)
Foreign currency translation gain (loss)	1,017,492		(481,107)
Unrealized loss on marketable securities	(39,194)	$ (26,215)	(62,950)	$ (134,626)
Comprehensive income (loss)	$ 307,038	$ (667,702)	$ (2,192,129)	$ (1,902,238)

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash Flows from Operating Activities:
Net loss	$ (1,648,072)	$ (1,767,612)
Adjustments to reconcile net loss to net cash provided by operating activities:
Stock-based compensation expense	741,145	864,059
Provision for (recovery of) doubtful accounts	95,546	(22,284)
Depreciation and amortization	2,115,678	$ 1,457,372
Deferred taxes	360,882
Deferred rent	(163,899)	$ (162,573)
Changes in operating assets and liabilities:
Accounts receivable	695,408	(194,955)
Other receivables	53,501	(81,422)
Prepaid expenses and other current assets	(217,295)	(77,543)
Other assets	(81,259)	12,620
Accounts payable	45,008	(165,429)
Accrued expenses	(2,103,315)	(239,147)
Deferred revenue	1,299,920	2,627,428
Other current liabilities	(396,373)	$ (223,843)
Other liabilities	(39,585)
Net cash provided by operating activities	757,290	$ 2,026,671
Cash Flows from Investing Activities:
Sale and maturity of marketable securities	2,005,484	5,356,309
Adjustment to purchase of Management Diagnostics Limited	50,494
Capital expenditures	(2,091,654)	(801,474)
Net cash (used in) provided by investing activities	(35,676)	4,554,835
Cash Flows from Financing Activities:
Cash dividends paid on common stock	(1,780,956)	(1,720,553)
Cash dividends paid on preferred stock	(192,848)	(192,848)
Proceeds from the exercise of stock options	839	$ 147,827
Restricted cash	139,750
Shares withheld on RSU vesting to pay for withholding taxes	(10,977)	$ (35,632)
Net cash used in financing activities	(1,844,192)	$ (1,801,206)
Effect of exchange rate changes on cash and cash equivalents	4,992
Net (decrease) increase in cash and cash equivalents	(1,117,586)	$ 4,780,300
Cash and cash equivalents, beginning of period	32,459,009	45,443,759
Cash and cash equivalents, end of period	$ 31,341,423	$ 50,224,059

DESCRIPTION OF THE BUSINESS AND

DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION	6 Months Ended
	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION Business TheStreet, Inc., together with its wholly owned subsidiaries (“TheStreet”, “we”, “us” or the “Company”), is a leading digital financial media company focused on the financial and mergers and acquisitions environment. The Company’s collection of digital services provides users, subscribers and advertisers with a variety of content and tools through a range of online, social media, tablet and mobile channels. Our mission is to provide investors and advisors with actionable ideas from the world of investing, finance and business, and dealmakers with sophisticated analysis of the mergers and acquisitions environment, in order to break down information barriers, level the playing field and help all individuals and organizations grow their wealth. With a robust suite of digital services, TheStreet offers the tools and insights needed to make informed decisions about earning, investing, saving and spending money. Since its inception in 1996, TheStreet believes it has distinguished itself from other financial media companies with its journalistic excellence, unbiased approach and interactive multimedia coverage of the financial markets, economy, industry trends, investment and financial planning. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and for quarterly reports on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The financial statements require the use of management estimates and include the accounts of the Company as required by GAAP. Operating results for the six month period ended June 30, 2015 is not necessarily indicative of the results that may be expected for the year ending December 31, 2015. The consolidated balance sheet at December 31, 2014 has been derived from the audited financial statements at that date, but does not include all of the information and notes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and accompanying notes included in the Company’s annual report on Form 10-K for the year ended December 31, 2014, filed with the Securities and Exchange Commission (“SEC”) on March 5, 2015 (“2014 Form 10-K”). The Company has evaluated subsequent events for recognition or disclosure. Recent Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which supersedes nearly all existing revenue recognition guidance under GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing GAAP. On July 9, 2015, the FASB voted to defer the effective date by one year to December 15, 2017 for interim and annual reporting periods beginning after that date. Early adoption of ASU 2014-09 is permitted but not before the original effective date (annual periods beginning after December 15, 2016). When effective, ASU 2014-09 will use either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients; or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our consolidated financial statements and have not yet determined the method by which we will adopt the standard. In January 2015, the FASB issued ASU 2015-01, Income Statement — Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items (“ASU 2015-01”). ASU 2015-01 eliminates the concept of extraordinary items from GAAP but retains the presentation and disclosure guidance for items that are unusual in nature or occur infrequently and expands the guidance to include items that are both unusual in nature and infrequently occurring. ASU 2015-01 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2015. A reporting entity may apply ASU 2015-01 prospectively. A reporting entity may also apply ASU 2015-01 retrospectively to all periods presented in the financial statements. We believe the adoption of ASU 2015-01 will not have a material effect on our consolidated financial statements.

ACQUISITION

ACQUISITION	6 Months Ended
	Jun. 30, 2015
Business Combinations [Abstract]
Business Combination Disclosure [Text Block]	2. ACQUISITION On October 31, 2014, the Company acquired all of the outstanding share capital of Management Diagnostics Limited (“MDL”), a privately held company headquartered in London, England. MDL is the owner of BoardEx, an institutional relationship capital management database and platform. The Company paid cash consideration of approximately $22.1 million at closing, of which $1.5 million was placed in escrow which will be used to secure indemnity obligations for a period of 24 months. Additionally, the Company assumed net liabilities approximating $5.0 million, inclusive of a potential earn-out payable in 2018 based on 2017 net revenue of BoardEx’s existing products and services. Concurrent with the signing of the agreement, the Company also purchased warranty insurance from Pembroke Syndicate 4000 at Lloyds with a policy limit of $5 million dollars, subject to a deductible. The results of operations of MDL are included in the Company’s condensed consolidated financial statements for the six months ended June 30, 2015. Unaudited pro forma consolidated financial information is presented below as if the acquisition of MDL had occurred on January 1, 2014. The historical financial statements of MDL were prepared in accordance with United Kingdom Generally Accepted Accounting Principles and have been converted to US Generally Accepted Accounting Principles for purposes of the unaudited pro forma consolidated financial information presented below. The results have been adjusted to account for the amortization of acquired intangible assets and to reclassify a defined benefit plan actuarial gain recorded by MDL within the statement of operations to accumulated other comprehensive income in accordance with U.S. generally accepted accounting principles. The pro forma information presented below does not purport to present what actual results would have been if the acquisition had occurred at the beginning of such period, nor does the information project results for any future period. The unaudited pro forma consolidated financial information should be read in conjunction with the historical financial information of the Company included in this report, as well as the historical financial information included in other reports and documents filed with the Securities and Exchange Commission. The unaudited pro forma consolidated financial information for the three and six months ended June 30, 2014 is as follows: For the Three Months Ended June 30, 2014 For the Six Months Ended June 30, 2014 Total revenue $ 17,323,171 $ 34,228,507 Net loss $ 474,309 $ 1,416,000 Basic and diluted net loss per share $ 0.01 $ 0.04

CASH AND CASH EQUIVALENTS, MARK

CASH AND CASH EQUIVALENTS, MARKETABLE SECURITIES AND RESTRICTED CASH	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block Supplement [Abstract]
Cash, Cash Equivalents, and Marketable Securities [Text Block]	3. CASH AND CASH EQUIVALENTS, MARKETABLE SECURITIES AND RESTRICTED CASH The Company’s cash, cash equivalents and restricted cash primarily consist of money market funds and checking accounts. As of June 30, 2015, marketable securities consist of two municipal auction rate securities (“ARS”) issued by the District of Columbia with a cost basis of approximately $1.9 million and a fair value of approximately $1.5 million. As of December 31, 2014, marketable securities also included an investment grade corporate bond, and the aggregate fair value of these marketable securities was approximately $3.6 million and the total cost basis was approximately $3.9 million. The decrease in marketable securities was due to the Company not reinvesting the proceeds as securities matured. With the exception of the ARS, the maximum maturity for any investment is three years. The ARS mature in the year 2038. The Company accounts for its marketable securities in accordance with the provisions of ASC 320-10. The Company classifies these securities as available for sale and the securities are reported at fair value. Unrealized gains and losses are recorded as a component of accumulated other comprehensive loss and excluded from net loss. Additionally, the Company has a total of approximately $1.2 million of cash that serves as collateral for outstanding letters of credit, and which cash is therefore restricted. The letters of credit serve as security deposits for the Company’s office space in New York City. June 30, 2015 December 31, 2014 Cash and cash equivalents $ 31,341,423 $ 32,459,009 Current and noncurrent marketable securities 1,540,000 3,569,240 Current and noncurrent restricted cash 1,161,250 1,301,000 Total cash and cash equivalents, current and noncurrent marketable securities and current and noncurrent restricted cash $ 34,042,673 $ 37,329,249

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	4. FAIR VALUE MEASUREMENTS The Company measures the fair value of its financial instruments in accordance with ASC 820-10, which refines the definition of fair value, provides a framework for measuring fair value and expands disclosures about fair value measurements. ASC 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The statement establishes consistency and comparability by providing a fair value hierarchy that prioritizes the inputs to valuation techniques into three broad levels, which are described below: • Level 1: Inputs are quoted market prices in active markets for identical assets or liabilities (these are observable market inputs). • Level 2: Inputs are inputs other than quoted market prices included within Level 1 that are observable for the asset or liability (includes quoted market prices for similar assets or identical or similar assets in markets in which there are few transactions, prices that are not current or vary substantially). • Level 3: Inputs are unobservable inputs that reflect the entity’s own assumptions in pricing the asset or liability (used when little or no market data is available). Financial assets and liabilities included in our financial statements and measured at fair value are classified based on the valuation technique level in the table below: As of June 30, 2015 Total Level 1 Level 2 Level 3 Description: Cash and cash equivalents (1) $ 31,341,423 $ 31,341,423 $ — $ — Restricted cash (1) 1,161,250 1,161,250 — — Marketable securities (2) 1,540,000 — — 1,540,000 Contingent earn-out (3) 2,524,023 — — 2,524,023 Total at fair value $ 36,566,696 $ 32,502,673 $ — $ 4,064,023 As of December 31, 2014 Total Level 1 Level 2 Level 3 Description: Cash and cash equivalents (1) $ 32,459,009 $ 32,459,009 $ — $ — Restricted cash (1) 1,301,000 1,301,000 — — Marketable securities (2) 3,569,240 2,009,240 — 1,560,000 Contingent earn-out (3) 2,602,105 — — 2,602,105 Total at fair value $ 39,931,354 $ 35,769,249 $ — $ 4,162,105 (1) Cash, cash equivalents and restricted cash, totaling approximately $32.5 million and $33.8 million as of June 30, 2015 and December 31, 2014, respectively, consist primarily of money market funds and checking accounts for which we determine fair value through quoted market prices. (2) Marketable securities as of December 31, 2014 include an investment grade corporate bond for which we determined fair value through quoted market prices. Marketable securities also consist of two municipal ARS issued by the District of Columbia having a fair value totaling approximately $1.5 million and $1.6 million as of June 30, 2015 and December 31, 2014, respectively. Historically, the fair value of ARS investments approximated par value due to the frequent resets through the auction process. Due to events in credit markets, the auction events, which historically have provided liquidity for these securities, have been unsuccessful. The result of a failed auction is that these ARS holdings will continue to pay interest in accordance with their terms at each respective auction date; however, liquidity of the securities will be limited until there is a successful auction, the issuer redeems the securities, the securities mature or until such time as other markets for these ARS holdings develop. For each of our ARS, we evaluate the risks related to the structure, collateral and liquidity of the investment, and forecast the probability of issuer default, auction failure, a successful auction at par, or a redemption at par, for each future auction period. Temporary impairment charges are recorded in accumulated other comprehensive loss, whereas other-than-temporary impairment charges are recorded in our consolidated statement of operations. As of June 30, 2015, the Company determined that there was a decline in the fair value of its ARS investments of $310 thousand from its cost basis, which was deemed temporary and was included within accumulated other comprehensive loss. The Company used both a discounted cash flow and market approach model to determine the estimated fair value of its ARS investments. The assumptions used in preparing the discounted cash flow model include estimates for interest rate, timing and amount of cash flows and expected holding period of ARS. (3) Contingent earn-out represents additional purchase consideration payable to the former shareholders of Management Diagnostics Limited based upon the achievement of specific 2017 audited revenue benchmarks. The probability of achieving each benchmark is based on Management’s assessment of the projected 2017 revenue. The present value of each probability weighted payment was calculated by discounting the probability weighted payment by the corresponding present value factor. The following tables provide a reconciliation of the beginning and ending balance for the Company’s assets and liabilities measured at fair value using significant unobservable inputs (Level 3): Marketable Securities Contingent Earn-Out Balance December 31, 2014 $ 1,560,000 $ 2,602,105 Change in fair value (20,000 ) - Purchase accounting adjustment - (144,398 ) Accretion of net present value - 66,316 Balance June 30, 2015 $ 1,540,000 $ 2,524,023

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	6 Months Ended
	Jun. 30, 2015
Stock-based Compensation
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	5. STOCK-BASED COMPENSATION The Company estimates the fair value of stock option awards on the date of grant using the Black-Scholes option-pricing model. This determination is affected by the Company’s stock price as well as assumptions regarding expected volatility, risk-free interest rate, and expected dividend yields. Because option-pricing models require the use of subjective assumptions, changes in these assumptions can materially affect the fair value of the options. The weighted-average grant date fair value per share of stock option awards granted during the six months ended June 30, 2015 and 2014 was $0.41 and $0.45, respectively, using the Black-Scholes model with the following weighted-average assumptions: For the Six Months Ended 2015 2014 Expected option lives 3.0 years 3.3 years Expected volatility 35.66 % 35.98 % Risk-free interest rate 0.99 % 0.94 % Expected dividend yield 4.51 % 4.11 % The value of each restricted stock unit awarded is equal to the closing price per share of the Company’s Common Stock on the date of grant. The weighted-average grant date fair value per share of restricted stock units granted during the six months ended June 30, 2015 and 2014 was $2.23 and $2.23, respectively. For both option and restricted stock unit awards, the value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods. As of June 30, 2015, there remained 1,788,838 shares available for future awards under the Company’s 2007 Performance Incentive Plan (the “2007 Plan”). In connection with awards under both the 2007 Plan and awards issued outside of the 2007 Plan, the Company recorded approximately $368 thousand and $741 thousand of noncash stock-based compensation for the three and six month periods ended June 30, 2015, respectively, as compared to approximately $417 thousand and $864 thousand of noncash stock-based compensation for the three and six month periods ended June 30, 2015 and 2014, respectively. As of June 30, 2015, there was approximately $2.7 million of unrecognized stock-based compensation expense remaining to be recognized over a weighted-average period of 2.2 years. A summary of the activity of the 2007 Plan, and awards issued outside of the 2007 Plan pertaining to stock option grants is as follows: Shares Weighted Aggregate Weighted Awards outstanding at December 31, 2014 4,246,041 $ 1.90 Options granted 37,795 $ 2.27 Options exercised (603 ) $ 1.39 Options forfeited (151,912 ) $ 1.88 Options expired (109,559 ) $ 2.74 Awards outstanding at June 30, 2015 4,021,762 $ 1.88 $ 186 3.39 Awards vested and expected to vest at June 30, 2015 3,911,029 $ 1.88 $ 183 3.39 Awards exercisable at June 30, 2015 2,668,722 $ 1.85 $ 133 3.35 A summary of the activity of the 2007 Plan pertaining to restricted stock unit grants is as follows: Shares Aggregate Weighted Awards outstanding at December 31, 2014 1,205,343 Restricted stock units granted 95,637 Restricted stock units vested (128,750 ) Restricted stock units forfeited (12,501 ) Awards outstanding at June 30, 2015 1,159,729 $ 2,099 2.35 Awards vested and expected to vest at June 30, 2015 1,137,229 $ 2,058 2.32 A summary of the status of the Company’s unvested share-based payment awards as of June 30, 2015 and changes in the six month period then ended, is as follows: Unvested Awards Number of Shares Weighted Average Grant Date Fair Value Shares underlying awards unvested at December 31, 2014 3,181,037 $ 1.16 Shares underlying options granted 37,795 $ 0.41 Shares underlying restricted stock units granted 95,637 $ 2.23 Shares underlying options vested (508,537 ) $ 0.52 Shares underlying restricted stock units vested (128,750 ) $ 2.21 Shares underlying options forfeited (151,912 ) $ 0.48 Shares underlying restricted stock units forfeited (12,501 ) $ 1.70 Shares underlying awards unvested at June 30, 2015 2,512,769 $ 1.30 For the six months ended June 30, 2015 and 2014, the total fair value of share-based awards vested was approximately $557 thousand and $969 thousand, respectively. For the six months ended June 30, 2015 and 2014, the total intrinsic value of options exercised was approximately $373 and $63 thousand, respectively. For the six months ended June 30, 2015 and 2014, approximately 38 thousand and 76 thousand stock options, respectively, were granted, and approximately 1 thousand and 80 thousand stock options, respectively, were exercised yielding approximately $1 thousand and $148 thousand, respectively, of cash proceeds to the Company. Additionally, for the six months ended June 30, 2015 and 2014, approximately 96 thousand and 471 thousand restricted stock units, respectively, were granted, and approximately 129 thousand and 269 thousand shares, respectively, were issued under restricted stock unit grants.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	6 Months Ended
	Jun. 30, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	6. STOCKHOLDERS’ EQUITY Treasury Stock In December 2000, the Company’s Board of Directors authorized the repurchase of up to $10 million of the Company’s Common Stock, from time to time, in private purchases or in the open market. In February 2004, the Company’s Board of Directors approved the resumption of the stock repurchase program (the “Program”) under new price and volume parameters, leaving unchanged the maximum amount available for repurchase under the Program. However, the affirmative vote of the holders of a majority of the outstanding shares of Series B Preferred Stock, voting separately as a single class, is necessary for the Company to repurchase its Common Stock (except for the purchase or redemption from employees, directors and consultants pursuant to agreements providing us with repurchase rights upon termination of their service with us), unless after such purchase we have unrestricted cash (net of all indebtedness for borrowed money, purchase money obligations, promissory notes or bonds) equal to at least two times the product obtained by multiplying the number of shares of Series B Preferred Stock outstanding at the time such dividend is paid by the liquidation preference. During the six-month periods ended June 30, 2015 and 2014, the Company did not purchase any shares of Common Stock under the Program. Since inception of the Program, the Company has purchased a total of 5,453,416 shares of Common Stock at an aggregate cost of approximately $7.3 million. In addition, pursuant to the terms of the Company’s 2007 Plan, and certain procedures adopted by the Compensation Committee of the Board of Directors, in connection with the exercise of stock options by certain of the Company’s employees, and the issuance of shares of Common Stock in settlement of vested restricted stock units, the Company may withhold shares in lieu of payment of the exercise price and/or the minimum amount of applicable withholding taxes then due. Through June 30, 2015, the Company had withheld an aggregate of 1,579,575 shares which have been recorded as treasury stock. In addition, the Company received an aggregate of 208,270 shares as partial settlement of the working capital and debt adjustment from the acquisition of Corsis Technology Group II LLC and 3,338 shares as partial settlement of the working capital adjustment from the acquisition of Kikucall, Inc. These shares have been recorded as treasury stock. Dividends During the three months ended June 30, 2015 and 2014, the Company paid a quarterly cash dividend of $0.025 per share on its Common Stock and its Series B Preferred Stock on a converted common share basis. The dividend payment totaled approximately $968 thousand and $957 thousand, respectively. When combined with the quarterly cash dividend paid during the three months ended March 31, 2015 and 2014, year-to-date dividends totaled approximately $2.0 million and $1.9 million, respectively.

LEGAL PROCEEDINGS

LEGAL PROCEEDINGS	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block Supplement [Abstract]
Legal Matters and Contingencies [Text Block]	7. LEGAL PROCEEDINGS The Company is party to legal proceedings arising in the ordinary course of business or otherwise, none of which is deemed material.

NET LOSS PER SHARE OF COMMON ST

NET LOSS PER SHARE OF COMMON STOCK	6 Months Ended
	Jun. 30, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	8. NET LOSS PER SHARE OF COMMON STOCK Basic net loss per share is computed using the weighted average number of common shares outstanding during the period. Diluted net loss per share is computed using the weighted average number of common shares and potential common shares outstanding during the period, so long as the inclusion of potential common shares does not result in a lower net loss per share. Potential common shares consist of restricted stock units (using the treasury stock method), the incremental common shares issuable upon the exercise of stock options (using the treasury stock method), and the conversion of the Company’s convertible preferred stock (using the if-converted method). For the three months ended June 30, 2015 and 2014, approximately 3.5 million and 6.0 million unvested restricted stock units and vested and unvested options to purchase Common Stock, respectively, were excluded from the calculation, as their effect would result in a lower net loss per share. For the six months ended June 30, 2015 and 2014, approximately 4.1 million and 5.9 million unvested restricted stock units and vested and unvested options to purchase Common Stock, respectively, were excluded from the calculation, as their effect would result in a lower net loss per share. The following table reconciles the numerator and denominator for the calculation. For the Three Months Ended June 30, For the Six Months Ended June 30, 2015 2014 2015 2014 Basic and diluted net loss per share: Numerator: Net loss $ (671,260 ) $ (641,487 ) $ (1,648,072 ) $ (1,767,612 ) Preferred stock cash dividends 96,424 96,424 192,848 192,848 Numerator for basic and diluted earnings per share Net loss attributable to common stockholders $ (767,684 ) $ (737,911 ) $ (1,840,920 ) $ (1,960,460 ) Denominator: Weighted average basic and diluted shares outstanding 34,848,571 34,367,669 34,814,060 34,287,410 Basic and diluted net loss per share: Net loss attributable to common stockholders $ (0.02 ) $ (0.02 ) $ (0.05 ) $ (0.06 )

INCOME TAXES

INCOME TAXES	6 Months Ended
	Jun. 30, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	9. INCOME TAXES Income tax expense for the three and six months ended June 30, 2015 was approximately $255 thousand and $487 thousand, respectively, and reflects an effective tax rate of -61% and -42%, respectively. There was no tax expense in the three or six months ended June 30, 2014. Tax expense for the three months ended June 30, 2015 primarily relates to the recognition of approximately $181 thousand of a deferred tax liability associated with goodwill that is tax deductible but constitutes an indefinite lived intangible asset for financial reporting purposes, as well as the recognition of approximately $74 thousand of income tax expense in certain jurisdictions where there are no net operating losses available to offset taxable income. Tax expense for the six months ended June 30, 2015 primarily relates to the recognition of approximately $361 thousand of a deferred tax liability associated with goodwill that is tax deductible but constitutes an indefinite lived intangible asset for financial reporting purposes, as well as the recognition of approximately $126 thousand of income tax expense in certain jurisdictions where there are no net operating losses available to offset taxable income. The Company accounts for its income taxes in accordance with ASC 740-10. Under ASC 740-10, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases. ASC 740-10 also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax assets will not be realized based on all available positive and negative evidence. The Company had approximately $149 million of federal and state net operating loss carryforwards as of December 31, 2014, which results in deferred tax assets of approximately $63 million. The Company has a full valuation allowance against its deferred tax assets as management concluded that it was more likely than not that the Company would not realize the benefit of its deferred tax assets by generating sufficient taxable income in future years. The Company expects to continue to provide a full valuation allowance until, or unless, it can sustain a level of profitability that demonstrates its ability to utilize these assets. Subject to potential Section 382 limitations as discussed below, the federal losses are available to offset future taxable income through 2034 and expire from 2019 through 2034. Since the Company does business in various states and each state has its own rules with respect to the number of years losses may be carried forward, the state net operating loss carryforwards expire from 2015 through 2034. The net operating loss carryforward as of December 31, 2014 includes approximately $16 million related to windfall tax benefits for which a benefit would be recorded to additional paid in capital when realized. Based on operating results for the six months ended June 30, 2015 and six month projections, management expects to generate a tax loss in 2015 and no tax benefit has been recorded. In accordance with Section 382 of the Internal Revenue Code, the ability to utilize the Company’s net operating loss carryforwards could be limited in the event of a change in ownership and as such a portion of the existing net operating loss carryforwards may be subject to limitation.

BUSINESS CONCENTRATIONS AND CRE

BUSINESS CONCENTRATIONS AND CREDIT RISK	6 Months Ended
	Jun. 30, 2015
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	10. BUSINESS CONCENTRATIONS AND CREDIT RISK Financial instruments that subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents and restricted cash. The Company maintains all of its cash, cash equivalents and restricted cash in seven financial institutions, and performs periodic evaluations of the relative credit standing of these institutions. As of June 30, 2015, the Company’s cash, cash equivalents and restricted cash primarily consisted of money market funds and checking accounts. For the three and six months ended June 30, 2015 and 2014, no individual client accounted for 10% or more of consolidated revenue. As of June 30, 2015 and December 31, 2014, no individual client accounted for more than 10% of our gross accounts receivable balance. The Company’s customers are primarily concentrated in the United States and Europe, and we carry accounts receivable balances. The Company performs ongoing credit evaluations, generally does not require collateral, and establishes an allowance for doubtful accounts based upon factors surrounding the credit risk of customers, historical trends and other information. To date, actual losses have been within management’s expectations.

RESTRUCTURING AND OTHER CHARGES

RESTRUCTURING AND OTHER CHARGES	6 Months Ended
	Jun. 30, 2015
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	11. RESTRUCTURING AND OTHER CHARGES During the year ended December 31, 2012, the Company implemented a targeted reduction in force. Additionally, in assessing the ongoing needs of the organization, the Company elected to discontinue using certain software as a service, consulting and data providers, and elected to write-off certain previously capitalized software development projects. The actions were taken after a review of the Company’s cost structure with the goal of better aligning the cost structure with the Company’s revenue base. These restructuring efforts resulted in restructuring and other charges of approximately $3.4 million during the year ended December 31, 2012. Additionally, as a result of the Company’s acquisition of The Deal, LLC (“the Deal”) in September 2012, the Company discontinued the use of The Deal’s office space and implemented a reduction in force to eliminate redundant positions, resulting in restructuring and other charges of approximately $3.5 million during the year ended December 31, 2012. Collectively, these activities are referred to as the “2012 Restructuring”. The following table displays the activity of the 2012 Restructuring reserve account during the six months ended June 30, 2015 and 2014. The remaining balance as of June 30, 2015 relates to the lease for The Deal’s office space which expires in August 2021. For the Six Months Ended June 30, 2015 2014 Beginning balance $ 1,384,736 $ 1,281,412 Adjustment to prior estimate 16,260 138,528 (Payments)/sublease income, net (74,240 ) 2,131 Ending balance $ 1,326,756 $ 1,422,071 In March 2009, the Company announced and implemented a reorganization plan, including an approximate 8% reduction in the Company’s workforce, to align the Company’s resources with its strategic business objectives. Additionally, effective March 21, 2009, the Company’s then Chief Executive Officer tendered his resignation, effective May 8, 2009, the Company’s then Chief Financial Officer tendered his resignation, and in December 2009, the Company sold its Promotions.com subsidiary and entered into negotiations to sublease certain office space maintained by Promotions.com. As a result of these activities, the Company incurred restructuring and other charges of approximately $3.5 million during the year ended December 31, 2009 (the “2009 Restructuring”). During the year ended December 31, 2012, the Company recorded a reduction to previously estimated charges resulting in a net credit of approximately $289 thousand. The following table displays the activity of the 2009 Restructuring reserve account during the six months ended June 30, 2014. Beginning balance $ 96,274 Adjustment to prior estimate (75,603 ) Net payments (20,671 ) Ending balance $ -

OTHER LIABILITIES

OTHER LIABILITIES	6 Months Ended
	Jun. 30, 2015
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]
Other Liabilities Disclosure [Text Block]	12. OTHER LIABILITIES Other liabilities consist of the following: June 30, 2015 December 31, 2014 Acquisition contingent earn-out $ 2,524,023 $ 2,602,105 Deferred rent 2,077,689 2,301,999 Restructuring charge 1,326,756 1,384,736 Deferred revenue 952,164 619,443 Other 42,104 1,892 Total other liabilities $ 6,922,736 $ 6,910,175

DESCRIPTION OF THE BUSINESS A19

DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION (Policies)	6 Months Ended
	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Description and Accounting Policies [Text Block]	Business TheStreet, Inc., together with its wholly owned subsidiaries (“TheStreet”, “we”, “us” or the “Company”), is a leading digital financial media company focused on the financial and mergers and acquisitions environment. The Company’s collection of digital services provides users, subscribers and advertisers with a variety of content and tools through a range of online, social media, tablet and mobile channels. Our mission is to provide investors and advisors with actionable ideas from the world of investing, finance and business, and dealmakers with sophisticated analysis of the mergers and acquisitions environment, in order to break down information barriers, level the playing field and help all individuals and organizations grow their wealth. With a robust suite of digital services, TheStreet offers the tools and insights needed to make informed decisions about earning, investing, saving and spending money. Since its inception in 1996, TheStreet believes it has distinguished itself from other financial media companies with its journalistic excellence, unbiased approach and interactive multimedia coverage of the financial markets, economy, industry trends, investment and financial planning.
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and for quarterly reports on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The financial statements require the use of management estimates and include the accounts of the Company as required by GAAP. The consolidated balance sheet at December 31, 2014 has been derived from the audited financial statements at that date, but does not include all of the information and notes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and accompanying notes included in the Company’s annual report on Form 10-K for the year ended December 31, 2014, filed with the Securities and Exchange Commission (“SEC”) on March 5, 2015 (“2014 Form 10-K”). The Company has evaluated subsequent events for recognition or disclosure.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which supersedes nearly all existing revenue recognition guidance under GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing GAAP. On July 9, 2015, the FASB voted to defer the effective date by one year to December 15, 2017 for interim and annual reporting periods beginning after that date. Early adoption of ASU 2014-09 is permitted but not before the original effective date (annual periods beginning after December 15, 2016). When effective, ASU 2014-09 will use either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients; or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our consolidated financial statements and have not yet determined the method by which we will adopt the standard. In January 2015, the FASB issued ASU 2015-01, (“ASU 2015-01”). ASU 2015-01 eliminates the concept of extraordinary items from GAAP but retains the presentation and disclosure guidance for items that are unusual in nature or occur infrequently and expands the guidance to include items that are both unusual in nature and infrequently occurring. ASU 2015-01 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2015. A reporting entity may apply ASU 2015-01 prospectively. A reporting entity may also apply ASU 2015-01 retrospectively to all periods presented in the financial statements. We believe the adoption of ASU 2015-01 will not have a material effect on our consolidated financial statements.

ACQUISITION (Tables)

ACQUISITION (Tables)	6 Months Ended
	Jun. 30, 2015
Business Combinations [Abstract]
Business Acquisition, Pro Forma Information [Table Text Block]	The unaudited pro forma consolidated financial information for the three and six months ended June 30, 2014 is as follows: For the Three Months Ended June 30, 2014 For the Six Months Ended June 30, 2014 Total revenue $ 17,323,171 $ 34,228,507 Net loss $ 474,309 $ 1,416,000 Basic and diluted net loss per share $ 0.01 $ 0.04

CASH AND CASH EQUIVALENTS, MA21

CASH AND CASH EQUIVALENTS, MARKETABLE SECURITIES AND RESTRICTED CASH (Tables)	6 Months Ended
	Jun. 30, 2015
Cash, Cash Equivalents, and Short-term Investments [Abstract]
Schedule Of Cash Cash Equivalents Marketable Securities And Restricted Cash [Table Text Block]	The letters of credit serve as security deposits for the Company’s office space in New York City. June 30, 2015 December 31, 2014 Cash and cash equivalents $ 31,341,423 $ 32,459,009 Current and noncurrent marketable securities 1,540,000 3,569,240 Current and noncurrent restricted cash 1,161,250 1,301,000 Total cash and cash equivalents, current and noncurrent marketable securities and current and noncurrent restricted cash $ 34,042,673 $ 37,329,249

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
Fair Value, Assets Measured on Recurring Basis [Table Text Block]	Financial assets and liabilities included in our financial statements and measured at fair value are classified based on the valuation technique level in the table below: As of June 30, 2015 Total Level 1 Level 2 Level 3 Description: Cash and cash equivalents (1) $ 31,341,423 $ 31,341,423 $ — $ — Restricted cash (1) 1,161,250 1,161,250 — — Marketable securities (2) 1,540,000 — — 1,540,000 Contingent earn-out (3) 2,524,023 — — 2,524,023 Total at fair value $ 36,566,696 $ 32,502,673 $ — $ 4,064,023 As of December 31, 2014 Total Level 1 Level 2 Level 3 Description: Cash and cash equivalents (1) $ 32,459,009 $ 32,459,009 $ — $ — Restricted cash (1) 1,301,000 1,301,000 — — Marketable securities (2) 3,569,240 2,009,240 — 1,560,000 Contingent earn-out (3) 2,602,105 — — 2,602,105 Total at fair value $ 39,931,354 $ 35,769,249 $ — $ 4,162,105 (1) Cash, cash equivalents and restricted cash, totaling approximately $32.5 million and $33.8 million as of June 30, 2015 and December 31, 2014, respectively, consist primarily of money market funds and checking accounts for which we determine fair value through quoted market prices. (2) Marketable securities as of December 31, 2014 include an investment grade corporate bond for which we determined fair value through quoted market prices. Marketable securities also consist of two municipal ARS issued by the District of Columbia having a fair value totaling approximately $1.5 million and $1.6 million as of June 30, 2015 and December 31, 2014, respectively. Historically, the fair value of ARS investments approximated par value due to the frequent resets through the auction process. Due to events in credit markets, the auction events, which historically have provided liquidity for these securities, have been unsuccessful. The result of a failed auction is that these ARS holdings will continue to pay interest in accordance with their terms at each respective auction date; however, liquidity of the securities will be limited until there is a successful auction, the issuer redeems the securities, the securities mature or until such time as other markets for these ARS holdings develop. For each of our ARS, we evaluate the risks related to the structure, collateral and liquidity of the investment, and forecast the probability of issuer default, auction failure, a successful auction at par, or a redemption at par, for each future auction period. Temporary impairment charges are recorded in accumulated other comprehensive loss, whereas other-than-temporary impairment charges are recorded in our consolidated statement of operations. As of June 30, 2015, the Company determined that there was a decline in the fair value of its ARS investments of $310 thousand from its cost basis, which was deemed temporary and was included within accumulated other comprehensive loss. The Company used both a discounted cash flow and market approach model to determine the estimated fair value of its ARS investments. The assumptions used in preparing the discounted cash flow model include estimates for interest rate, timing and amount of cash flows and expected holding period of ARS. (3) Contingent earn-out represents additional purchase consideration payable to the former shareholders of Management Diagnostics Limited based upon the achievement of specific 2017 audited revenue benchmarks. The probability of achieving each benchmark is based on Management’s assessment of the projected 2017 revenue. The present value of each probability weighted payment was calculated by discounting the probability weighted payment by the corresponding present value factor.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	The following tables provide a reconciliation of the beginning and ending balance for the Company’s assets and liabilities measured at fair value using significant unobservable inputs (Level 3): Marketable Contingent Balance December 31, 2014 $ 1,560,000 $ 2,602,105 Change in fair value (20,000 ) - Purchase accounting adjustment - (144,398 ) Accretion of net present value - 66,316 Balance June 30, 2015 $ 1,540,000 $ 2,524,023

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	6 Months Ended
	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	The weighted-average grant date fair value per share of stock option awards granted during the six months ended June 30, 2015 and 2014 was $0.41 and $0.45, respectively, using the Black-Scholes model with the following weighted-average assumptions: For the Six Months Ended June 30, 2015 2014 Expected option lives 3.0 years 3.3 years Expected volatility 35.66 % 35.98 % Risk-free interest rate 0.99 % 0.94 % Expected dividend yield 4.51 % 4.11 %
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	A summary of the activity of the 2007 Plan, and awards issued outside of the 2007 Plan pertaining to stock option grants is as follows: Shares Underlying Awards Weighted Average Exercise Price Aggregate Intrinsic Value ($000) Weighted Average Remaining Contractual Life (In Years) Awards outstanding at December 31, 2014 4,246,041 $ 1.90 Options granted 37,795 $ 2.27 Options exercised (603 ) $ 1.39 Options forfeited (151,912 ) $ 1.88 Options expired (109,559 ) $ 2.74 Awards outstanding at June 30, 2015 4,021,762 $ 1.88 $ 186 3.39 Awards vested and expected to vest at June 30, 2015 3,911,029 $ 1.88 $ 183 3.39 Awards exercisable at June 30, 2015 2,668,722 $ 1.85 $ 133 3.35
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	A summary of the activity of the 2007 Plan pertaining to restricted stock unit grants is as follows: Shares Underlying Awards Aggregate Intrinsic Value ($000) Weighted Average Remaining Contractual Life (In Years) Awards outstanding at December 31, 2014 1,205,343 Restricted stock units granted 95,637 Restricted stock units vested (128,750 ) Restricted stock units forfeited (12,501 ) Awards outstanding at June 30, 2015 1,159,729 $ 2,099 2.35 Awards vested and expected to vest at June 30, 2015 1,137,229 $ 2,058 2.32
Schedule Of Unvested Share Based Payment Awards [Table Text Block]	A summary of the status of the Company’s unvested share-based payment awards as of June 30, 2015 and changes in the six month period then ended, is as follows: Unvested Awards Number of Shares Weighted Average Grant Date Fair Value Shares underlying awards unvested at December 31, 2014 3,181,037 $ 1.16 Shares underlying options granted 37,795 $ 0.41 Shares underlying restricted stock units granted 95,637 $ 2.23 Shares underlying options vested (508,537 ) $ 0.52 Shares underlying restricted stock units vested (128,750 ) $ 2.21 Shares underlying options forfeited (151,912 ) $ 0.48 Shares underlying restricted stock units forfeited (12,501 ) $ 1.70 Shares underlying awards unvested at June 30, 2015 2,512,769 $ 1.30

NET LOSS PER SHARE OF COMMON 24

NET LOSS PER SHARE OF COMMON STOCK (Tables)	6 Months Ended
	Jun. 30, 2015
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table reconciles the numerator and denominator for the calculation. For the Three Months Ended June 30, For the Six Months Ended June 30, 2015 2014 2015 2014 Basic and diluted net loss per share: Numerator: Net loss $ (671,260 ) $ (641,487 ) $ (1,648,072 ) $ (1,767,612 ) Preferred stock cash dividends 96,424 96,424 192,848 192,848 Numerator for basic and diluted earnings per share Net loss attributable to common stockholders $ (767,684 ) $ (737,911 ) $ (1,840,920 ) $ (1,960,460 ) Denominator: Weighted average basic and diluted shares outstanding 34,848,571 34,367,669 34,814,060 34,287,410 Basic and diluted net loss per share: Net loss attributable to common stockholders $ (0.02 ) $ (0.02 ) $ (0.05 ) $ (0.06 )

RESTRUCTURING AND OTHER CHARG25

RESTRUCTURING AND OTHER CHARGES (Tables)	6 Months Ended
	Jun. 30, 2015
Restructuring Reserve 2012 [Member]
Schedule Of Restructuring Reserve Activity [Table Text Block]	The following table displays the activity of the 2012 Restructuring reserve account during the six months ended June 30, 2015 and 2014. The remaining balance as of June 30, 2015 relates to the lease for The Deal’s office space which expires in August 2021. For the Six Months Ended June 30, 2015 2014 Beginning balance $ 1,384,736 $ 1,281,412 Adjustment to prior estimate 16,260 138,528 (Payments)/sublease income, net (74,240 ) 2,131 Ending balance $ 1,326,756 $ 1,422,071
Restructuring Reserve 2009 [Member]
Schedule Of Restructuring Reserve Activity [Table Text Block]	The following table displays the activity of the 2009 Restructuring reserve account during the six months ended June 30, 2014. Beginning balance $ 96,274 Adjustment to prior estimate (75,603 ) Net payments (20,671 ) Ending balance $ -

OTHER LIABILITIES (Tables)

OTHER LIABILITIES (Tables)	6 Months Ended
	Jun. 30, 2015
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]
Other Liabilities [Table Text Block]	Other liabilities consist of the following: June 30, 2015 December 31, 2014 Acquisition contingent earn-out $ 2,524,023 $ 2,602,105 Deferred rent 2,077,689 2,301,999 Restructuring charge 1,326,756 1,384,736 Deferred revenue 952,164 619,443 Other 42,104 1,892 Total other liabilities $ 6,922,736 $ 6,910,175

ACQUISITION (Details) - Busines

ACQUISITION (Details) - Business Acquisition, Pro Forma Information - Jun. 30, 2014 - USD ($)	Total	Total
Business Acquisition, Pro Forma Information [Abstract]
Total Revenue	$ 17,323,171	$ 34,228,507
Net Loss	$ 474,309	$ 1,416,000
Basic and diluted net loss per share	$ 0.01	$ 0.04

ACQUISITION (Details)

ACQUISITION (Details) - Jun. 30, 2015 - Management Diagnostics Limited [Member] - USD ($)	Total
Business Acquisition [Line Items]
Business Acquisition, Name of Acquired Entity	Management Diagnostics Limited
Payments to Acquire Businesses, Gross	$ 22,100,000
Escrow Deposit	$ 1,500,000
Escrow Agreement Secure Indemnity Obligations Period	24 months
Business Combination, Consideration Transferred, Liabilities Incurred	$ 5,000,000
Warranty Insurance, Policy Limit	$ 5,000,000

CASH AND CASH EQUIVALENTS, MA29

CASH AND CASH EQUIVALENTS, MARKETABLE SECURITIES AND RESTRICTED CASH (Details) - Cash and cash equivalents - USD ($)		Jun. 30, 2015	Dec. 31, 2014	Jun. 30, 2014	Dec. 31, 2013
Cash, Cash Equivalents, and Short-term Investments [Abstract]
Cash and cash equivalents		$ 31,341,423	$ 32,459,009	$ 50,224,059	$ 45,443,759
Current and noncurrent marketable securities	[1]	1,540,000	3,569,240
Current and noncurrent restricted cash	[2]	1,161,250	1,301,000
Total cash and cash equivalents, current and noncurrent marketable securities and current and noncurrent restricted cash		$ 34,042,673	$ 37,329,249
[1]	Marketable securities as of December 31, 2014 include an investment grade corporate bond for which we determined fair value through quoted market prices. Marketable securities also consist of two municipal ARS issued by the District of Columbia having a fair value totaling approximately $1.5 million and $1.6 million as of June 30, 2015 and December 31, 2014, respectively. Historically, the fair value of ARS investments approximated par value due to the frequent resets through the auction process. Due to events in credit markets, the auction events, which historically have provided liquidity for these securities, have been unsuccessful. The result of a failed auction is that these ARS holdings will continue to pay interest in accordance with their terms at each respective auction date; however, liquidity of the securities will be limited until there is a successful auction, the issuer redeems the securities, the securities mature or until such time as other markets for these ARS holdings develop. For each of our ARS, we evaluate the risks related to the structure, collateral and liquidity of the investment, and forecast the probability of issuer default, auction failure, a successful auction at par, or a redemption at par, for each future auction period. Temporary impairment charges are recorded in accumulated other comprehensive loss, whereas other-than-temporary impairment charges are recorded in our consolidated statement of operations. As of June 30, 2015, the Company determined that there was a decline in the fair value of its ARS investments of $310 thousand from its cost basis, which was deemed temporary and was included within accumulated other comprehensive loss. The Company used both a discounted cash flow and market approach model to determine the estimated fair value of its ARS investments. The assumptions used in preparing the discounted cash flow model include estimates for interest rate, timing and amount of cash flows and expected holding period of ARS.
[2]	Cash, cash equivalents and restricted cash, totaling approximately $32.5 million and $33.8 million as of June 30, 2015 and December 31, 2014, respectively, consist primarily of money market funds and checking accounts for which we determine fair value through quoted market prices.

CASH AND CASH EQUIVALENTS, MA30

CASH AND CASH EQUIVALENTS, MARKETABLE SECURITIES AND RESTRICTED CASH (Details) - USD ($)		Jun. 30, 2015	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Marketable securities fair value		$ 1,500,000
Marketable Securities	[1]	1,540,000	$ 3,569,240
Cost Basis Of Marketable Securities		1,900,000	3,900,000
Restricted Cash and Cash Equivalents	[2]	$ 1,161,250	$ 1,301,000
[1]	Marketable securities as of December 31, 2014 include an investment grade corporate bond for which we determined fair value through quoted market prices. Marketable securities also consist of two municipal ARS issued by the District of Columbia having a fair value totaling approximately $1.5 million and $1.6 million as of June 30, 2015 and December 31, 2014, respectively. Historically, the fair value of ARS investments approximated par value due to the frequent resets through the auction process. Due to events in credit markets, the auction events, which historically have provided liquidity for these securities, have been unsuccessful. The result of a failed auction is that these ARS holdings will continue to pay interest in accordance with their terms at each respective auction date; however, liquidity of the securities will be limited until there is a successful auction, the issuer redeems the securities, the securities mature or until such time as other markets for these ARS holdings develop. For each of our ARS, we evaluate the risks related to the structure, collateral and liquidity of the investment, and forecast the probability of issuer default, auction failure, a successful auction at par, or a redemption at par, for each future auction period. Temporary impairment charges are recorded in accumulated other comprehensive loss, whereas other-than-temporary impairment charges are recorded in our consolidated statement of operations. As of June 30, 2015, the Company determined that there was a decline in the fair value of its ARS investments of $310 thousand from its cost basis, which was deemed temporary and was included within accumulated other comprehensive loss. The Company used both a discounted cash flow and market approach model to determine the estimated fair value of its ARS investments. The assumptions used in preparing the discounted cash flow model include estimates for interest rate, timing and amount of cash flows and expected holding period of ARS.
[2]	Cash, cash equivalents and restricted cash, totaling approximately $32.5 million and $33.8 million as of June 30, 2015 and December 31, 2014, respectively, consist primarily of money market funds and checking accounts for which we determine fair value through quoted market prices.

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - Summary of Assets and Liabilities Measured at Fair Value - USD ($)		Jun. 30, 2015	Dec. 31, 2014
Description:
Cash and cash equivalents	[1]	$ 31,341,423	$ 32,459,009
Restricted cash	[1]	1,161,250	1,301,000
Marketable securities	[2]	1,540,000	3,569,240
Contingent earn-out	[3]	2,524,023	2,602,105
Total at fair value		36,566,696	39,931,354
Level 1 [Member]
Description:
Cash and cash equivalents	[1]	31,341,423	32,459,009
Restricted cash	[1]	$ 1,161,250	1,301,000
Marketable securities	[2]		$ 2,009,240
Contingent earn-out	[3]
Total at fair value		$ 32,502,673	$ 35,769,249
Level 2 [Member]
Description:
Cash and cash equivalents	[1]
Restricted cash	[1]
Marketable securities	[2]
Contingent earn-out	[3]
Total at fair value
Level 3 [Member]
Description:
Cash and cash equivalents	[1]
Restricted cash	[1]
Marketable securities	[2]	$ 1,540,000	$ 1,560,000
Contingent earn-out	[3]	2,524,023	2,602,105
Total at fair value		$ 4,064,023	$ 4,162,105
[1]	Cash, cash equivalents and restricted cash, totaling approximately $32.5 million and $33.8 million as of June 30, 2015 and December 31, 2014, respectively, consist primarily of money market funds and checking accounts for which we determine fair value through quoted market prices.
[2]	Marketable securities as of December 31, 2014 include an investment grade corporate bond for which we determined fair value through quoted market prices. Marketable securities also consist of two municipal ARS issued by the District of Columbia having a fair value totaling approximately $1.5 million and $1.6 million as of June 30, 2015 and December 31, 2014, respectively. Historically, the fair value of ARS investments approximated par value due to the frequent resets through the auction process. Due to events in credit markets, the auction events, which historically have provided liquidity for these securities, have been unsuccessful. The result of a failed auction is that these ARS holdings will continue to pay interest in accordance with their terms at each respective auction date; however, liquidity of the securities will be limited until there is a successful auction, the issuer redeems the securities, the securities mature or until such time as other markets for these ARS holdings develop. For each of our ARS, we evaluate the risks related to the structure, collateral and liquidity of the investment, and forecast the probability of issuer default, auction failure, a successful auction at par, or a redemption at par, for each future auction period. Temporary impairment charges are recorded in accumulated other comprehensive loss, whereas other-than-temporary impairment charges are recorded in our consolidated statement of operations. As of June 30, 2015, the Company determined that there was a decline in the fair value of its ARS investments of $310 thousand from its cost basis, which was deemed temporary and was included within accumulated other comprehensive loss. The Company used both a discounted cash flow and market approach model to determine the estimated fair value of its ARS investments. The assumptions used in preparing the discounted cash flow model include estimates for interest rate, timing and amount of cash flows and expected holding period of ARS.
[3]	Contingent earn-out represents additional purchase consideration payable to the former shareholders of Management Diagnostics Limited based upon the achievement of specific 2017 audited revenue benchmarks. The probability of achieving each benchmark is based on Management's assessment of the projected 2017 revenue. The present value of each probability weighted payment was calculated by discounting the probability weighted payment by the corresponding present value factor.

FAIR VALUE MEASUREMENTS (Deta32

FAIR VALUE MEASUREMENTS (Details) - Summary of Marketable Securities Measured at Fair Value	6 Months Ended
	Jun. 30, 2015USD ($)
Marketable Securities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of the period	$ 1,560,000
Change in fair value	$ (20,000)
Purchase accounting adjustment
Accretion of net present value
Balance at end of the period	$ 1,540,000
Contingent Earn-Out [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of the period	$ 2,602,105
Change in fair value
Purchase accounting adjustment	$ (144,398)
Accretion of net present value	66,316
Balance at end of the period	$ 2,668,421

FAIR VALUE MEASUREMENTS (Deta33

FAIR VALUE MEASUREMENTS (Details) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash, Cash Equivalents, and Restricted Cash	$ 32,500,000	$ 33,800,000
Two Municipal Auction Rate Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Auction Rate Securities, Noncurrent	1,500,000	$ 1,600,000
Auction Rate Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax	$ 310,000

STOCK-BASED COMPENSATION (Detai

STOCK-BASED COMPENSATION (Details) - Value of Employee Stock Options on the Date of Grant	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Expected option lives	3.0 years	3.3 years
Expected volatility	35.66%	35.98%
Risk-free interest rate	0.99%	0.94%
Expected dividend yield	4.51%	4.11%

STOCK-BASED COMPENSATION (Det35

STOCK-BASED COMPENSATION (Details) - Summary of Stock Options Activity - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Awards outstanding at December 31, 2014	4,246,041
Awards outstanding at December 31, 2014	$ 1.90
Options granted	37,795	76,000
Options granted	$ 2.27
Options exercised	(1,000)	(80,000)
Options exercised	$ 1.39
Options forfeited	(151,912)
Options forfeited	$ 1.88
Options expired	(109,559)
Options expired	$ 2.74
Awards outstanding at June 30, 2015	4,021,762
Awards outstanding at June 30, 2015	$ 1.88
Awards outstanding at June 30, 2015	$ 186
Awards outstanding at June 30, 2015	3 years 4 months 21 days
Awards vested and expected to vest at June 30, 2015	3,911,029
Awards vested and expected to vest at June 30, 2015	$ 1.88
Awards vested and expected to vest at June 30, 2015	$ 183
Awards vested and expected to vest at June 30, 2015	3 years 4 months 21 days
Awards exercisable at June 30, 2015	2,668,722
Awards exercisable at June 30, 2015	$ 1.85
Awards exercisable at June 30, 2015	$ 133
Awards exercisable at June 30, 2015	3 years 4 months 6 days

STOCK-BASED COMPENSATION (Det36

STOCK-BASED COMPENSATION (Details) - Summary of Restricted Stock Units Activity - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Awards outstanding at December 31, 2014	1,205,343
Restricted stock units granted	95,637	471,000
Restricted stock units vested	(128,750)	(269,000)
Restricted stock units cancelled	(12,501)
Awards outstanding at June 30, 2015	1,159,729
Awards outstanding at June 30, 2015 (in Dollars)	$ 2,099
Awards outstanding at June 30, 2015	2 years 4 months 6 days
Awards vested and expected to vest at June 30, 2015	1,137,229
Awards vested and expected to vest at June 30, 2015 (in Dollars)	$ 2,058
Awards vested and expected to vest at June 30, 2015	2 years 3 months 26 days

STOCK-BASED COMPENSATION (Det37

STOCK-BASED COMPENSATION (Details) - Status Of Unvested Share-based Payment Awards - $ / shares	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Shares underlying awards unvested at December 31, 2014	3,181,037
Shares underlying awards unvested at December 31, 2014	$ 1.16
Shares underlying options granted	37,795	76,000
Shares underlying options granted	$ 0.41	$ 0.45
Shares underlying restricted stock units granted	95,637	471,000
Shares underlying restricted stock units granted	$ 2.23	$ 2.23
Shares underlying options vested	(508,537)
Shares underlying options vested	$ 0.52
Shares underlying restricted stock units vested	(128,750)	(269,000)
Shares underlying restricted stock units vested	$ 2.21
Shares underlying options cancelled	(151,912)
Shares underlying options cancelled	$ 0.48
Shares underlying restricted stock units cancelled	12,501
Shares underlying restricted stock units cancelled	$ 1.70
Shares underlying awards unvested at June 30, 2015	2,512,769
Shares underlying awards unvested at June 30, 2015	$ 1.30

STOCK-BASED COMPENSATION (Det38

STOCK-BASED COMPENSATION (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)			$ 0.41	$ 0.45
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)			$ 2.23	$ 2.23
Share-based Compensation			$ 741,145	$ 864,059
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value			557,000	969,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value			$ 373,000	$ 63,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures (in Shares)			37,795	76,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)			1,000	80,000
Proceeds from Stock Options Exercised			$ 839	$ 147,827
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares)			95,637	471,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (in Shares)			128,750	269,000
Performance Incentive Plan 2007 [Member]
Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	1,788,838		1,788,838
Share-based Compensation	$ 368,000	$ 417,000	$ 741,000	$ 864,000
Unrecognized stock-based compensation expense	$ 2,700,000		$ 2,700,000
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition In Years			2 years 2 months 12 days

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details) - USD ($)	3 Months Ended				102 Months Ended	186 Months Ended
	Jun. 30, 2015	Mar. 31, 2015	Jun. 30, 2014	Mar. 31, 2014	Jun. 30, 2015	Jun. 30, 2015	Dec. 31, 2000
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount							$ 10,000,000
Treasury Stock, Shares, Acquired (in Shares)						5,453,416
Treasury Stock, Value, Acquired, Cost Method						$ 7,300,000
Business Acquisition, Shares Received For Settlement (in Shares)						1,579,575
Dividends, Cash (in Dollars)		$ 2,000,000		$ 1,900,000
Kikucall Inc [Member]
Class of Stock [Line Items]
Business Acquisition, Shares Received For Settlement (in Shares)					3,338
Corsis Technology Group IILLC [Member]
Class of Stock [Line Items]
Business Acquisition, Shares Received For Settlement (in Shares)					208,270
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Dividends, Per Share, Cash Paid (in Dollars per share)	$ 0.025		$ 0.025
Convertible Common Stock [Member]
Class of Stock [Line Items]
Common Stock, Dividends, Per Share, Cash Paid (in Dollars per share)	$ 0.025		$ 0.025

NET LOSS PER SHARE OF COMMON 40

NET LOSS PER SHARE OF COMMON STOCK (Details) - Summary of Earnings Per Share Reconcilation - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Numerator:
Net loss	$ (671,260)	$ (641,487)	$ (1,648,072)	$ (1,767,612)
Preferred stock cash dividends	96,424	96,424	192,848	192,848
Numerator for basic and diluted earnings per share
Net loss attributable to common stockholders	$ (767,684)	$ (737,911)	$ (1,840,920)	$ (1,960,460)
Denominator:
Weighted average basic and diluted shares outstanding	34,848,571	34,367,669	34,814,060	34,287,410
Basic and diluted net loss per share:
Net loss attributable to common stockholders	$ (0.02)	$ (0.02)	$ (0.05)	$ (0.06)

NET LOSS PER SHARE OF COMMON 41

NET LOSS PER SHARE OF COMMON STOCK (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Earnings Per Share [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,500,000	6,000,000	4,100,000	5,900,000

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Income Taxes [Line Items]
Income tax expense	$ 254,591		$ 487,032
Effective tax rate	(61.00%)		(42.00%)
Tax expense for deferred tax liability	$ 181,000		$ 361,000
Income tax expense in certain jurisdictions	$ 74,000		$ 126,000
Operating Loss Carryforwards					$ 149,000,000
Operating Loss Carryforwards, Windfall Tax Benefits					16,000,000
Deferred tax assets					$ 63,000,000
Operating Loss Carryforwards, expiration date			expire from 2019 through 2034
Tax expense relates to the recognition of deferred tax liability with goodwill			$ 360,882
State net operating loss carryforwards [Member]
Income Taxes [Line Items]
Operating Loss Carryforwards, expiration date			expire from 2019 through 2034

BUSINESS CONCENTRATIONS AND C43

BUSINESS CONCENTRATIONS AND CREDIT RISK (Details)	6 Months Ended
	Jun. 30, 2015
Risks and Uncertainties [Abstract]
Concentration Risk, Customer	For the three and six months ended June 30, 2015 and 2014, no individual client accounted for 10% or more of consolidated revenue. As of June 30, 2015 and December 31, 2014, no individual client accounted for more than 10% of our gross accounts receivable balance.

RESTRUCTURING AND OTHER CHARG44

RESTRUCTURING AND OTHER CHARGES (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2012	Dec. 31, 2009
Restructuring Reserve 2009 [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		$ 289,000	$ 3,500,000
Restructuring and Related Cost, Number of Positions Eliminated, Period Percent			8.00%
Restructuring Reserve 2012 [Member]
Restructuring Cost and Reserve [Line Items]
Lease expiration date	Aug. 31, 2021
Restructuring Reserve 2012 [Member] | Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		3,400,000
Restructuring Reserve 2012 [Member] | The Deal LLC [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		$ 3,500,000

RESTRUCTURING AND OTHER CHARG45

RESTRUCTURING AND OTHER CHARGES (Details) - Summary of Restructuring Reserve Activity 2012 - Restructuring Reserve 2012 [Member] - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Restructuring Cost and Reserve [Line Items]
Beginning balance	$ 1,384,736	$ 1,281,412
Adjustment to prior estimate	16,260	138,528
(Payments)/sublease income, net	(74,240)	2,131
Ending balance	$ 1,326,756	$ 1,422,071

RESTRUCTURING AND OTHER CHARG46

RESTRUCTURING AND OTHER CHARGES (Details) - Summary of Restructuring Reserve Activity 2009 - Restructuring Reserve 2009 [Member]	6 Months Ended
	Jun. 30, 2014USD ($)
Restructuring Cost and Reserve [Line Items]
Beginning balance	$ 96,274
Adjustment to prior estimate	(75,603)
Net payments	(20,671)
Ending balance	$ 0

OTHER LIABILITIES (Details) - S

OTHER LIABILITIES (Details) - Summary of Other Liabilities - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Summary Of Other Liabilities [Abstract]
Acquisition contingent earn-out	$ 2,524,023	$ 2,602,105
Deferred rent	2,077,689	2,301,999
Restructuring charge	1,326,756	1,384,736
Deferred revenue	952,164	619,443
Other	42,104	1,892
Total other liabilities	$ 6,922,736	$ 6,910,175